
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action
Elodie M. Varin, Erin E. Mulvihill, Laurie L. Baggio, et al.
Cell Reports (2019) Vol. 27, Iss. 11, pp. 3371-3384.e3
Open Access | Times Cited: 83
Elodie M. Varin, Erin E. Mulvihill, Laurie L. Baggio, et al.
Cell Reports (2019) Vol. 27, Iss. 11, pp. 3371-3384.e3
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
Glucagon-like peptide 1 (GLP-1)
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1306
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1306
GLP-1 physiology informs the pharmacotherapy of obesity
Daniel J. Drucker
Molecular Metabolism (2021) Vol. 57, pp. 101351-101351
Open Access | Times Cited: 274
Daniel J. Drucker
Molecular Metabolism (2021) Vol. 57, pp. 101351-101351
Open Access | Times Cited: 274
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
Brent A. McLean, Chi Kin Wong, Jonathan E. Campbell, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 101-132
Open Access | Times Cited: 195
Brent A. McLean, Chi Kin Wong, Jonathan E. Campbell, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 101-132
Open Access | Times Cited: 195
Central and peripheral GLP-1 systems independently suppress eating
Daniel I. Brierley, Marie K. Holt, Arashdeep Singh, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 258-273
Open Access | Times Cited: 176
Daniel I. Brierley, Marie K. Holt, Arashdeep Singh, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 258-273
Open Access | Times Cited: 176
Role of the gut–brain axis in energy and glucose metabolism
Hallie Wachsmuth, Savanna N. Weninger, Frank A. Duca
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 377-392
Open Access | Times Cited: 129
Hallie Wachsmuth, Savanna N. Weninger, Frank A. Duca
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 377-392
Open Access | Times Cited: 129
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Rola Hammoud, Daniel J. Drucker
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 201-216
Closed Access | Times Cited: 127
Rola Hammoud, Daniel J. Drucker
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 201-216
Closed Access | Times Cited: 127
The metabolic impact of small intestinal nutrient sensing
Frank A. Duca, T.M. Zaved Waise, Willem T. Peppler, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 126
Frank A. Duca, T.M. Zaved Waise, Willem T. Peppler, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 126
The expanding incretin universe: from basic biology to clinical translation
Daniel J. Drucker, Jens J. Holst
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1765-1779
Open Access | Times Cited: 117
Daniel J. Drucker, Jens J. Holst
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1765-1779
Open Access | Times Cited: 117
An inter-organ neural circuit for appetite suppression
Tong Zhang, Matthew H. Perkins, Hao Chang, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2478-2494.e28
Open Access | Times Cited: 108
Tong Zhang, Matthew H. Perkins, Hao Chang, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2478-2494.e28
Open Access | Times Cited: 108
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation
Chi Kin Wong, Brent A. McLean, Laurie L. Baggio, et al.
Cell Metabolism (2023) Vol. 36, Iss. 1, pp. 130-143.e5
Closed Access | Times Cited: 90
Chi Kin Wong, Brent A. McLean, Laurie L. Baggio, et al.
Cell Metabolism (2023) Vol. 36, Iss. 1, pp. 130-143.e5
Closed Access | Times Cited: 90
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Julian M. Yabut, Daniel J. Drucker
Endocrine Reviews (2022) Vol. 44, Iss. 1, pp. 14-32
Open Access | Times Cited: 70
Julian M. Yabut, Daniel J. Drucker
Endocrine Reviews (2022) Vol. 44, Iss. 1, pp. 14-32
Open Access | Times Cited: 70
Targeting the incretin system in obesity and type 2 diabetes mellitus
Saleem Ansari, Bernard Khoo, Tricia Tan
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 8, pp. 447-459
Closed Access | Times Cited: 30
Saleem Ansari, Bernard Khoo, Tricia Tan
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 8, pp. 447-459
Closed Access | Times Cited: 30
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation
Chi Kin Wong, Bernardo Yusta, Jacqueline A. Koehler, et al.
Cell Metabolism (2022) Vol. 34, Iss. 10, pp. 1514-1531.e7
Open Access | Times Cited: 60
Chi Kin Wong, Bernardo Yusta, Jacqueline A. Koehler, et al.
Cell Metabolism (2022) Vol. 34, Iss. 10, pp. 1514-1531.e7
Open Access | Times Cited: 60
Autonomic control of energy balance and glucose homeostasis
Uisu Hyun, Jong‐Woo Sohn
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 370-376
Open Access | Times Cited: 46
Uisu Hyun, Jong‐Woo Sohn
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 370-376
Open Access | Times Cited: 46
Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?
Zaman Mirzadeh, Chelsea L. Faber, Michael W. Schwartz
The Annual Review of Pharmacology and Toxicology (2022) Vol. 62, Iss. 1, pp. 55-84
Open Access | Times Cited: 39
Zaman Mirzadeh, Chelsea L. Faber, Michael W. Schwartz
The Annual Review of Pharmacology and Toxicology (2022) Vol. 62, Iss. 1, pp. 55-84
Open Access | Times Cited: 39
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1846-1858
Open Access | Times Cited: 27
Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1846-1858
Open Access | Times Cited: 27
Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function
Wenran Ren, Jianhui Chen, Wenjing Wang, et al.
Neuron (2024) Vol. 112, Iss. 6, pp. 972-990.e8
Open Access | Times Cited: 10
Wenran Ren, Jianhui Chen, Wenjing Wang, et al.
Neuron (2024) Vol. 112, Iss. 6, pp. 972-990.e8
Open Access | Times Cited: 10
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Simon Hoffman, Khosrow Adeli
Medical Review (2024) Vol. 4, Iss. 4, pp. 301-311
Open Access | Times Cited: 8
Simon Hoffman, Khosrow Adeli
Medical Review (2024) Vol. 4, Iss. 4, pp. 301-311
Open Access | Times Cited: 8
GLP-1 programs the neurovascular landscape
Bandy Chen, Xiaofei Yu, Claudia Horvath-Diano, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2173-2189
Closed Access | Times Cited: 8
Bandy Chen, Xiaofei Yu, Claudia Horvath-Diano, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2173-2189
Closed Access | Times Cited: 8
Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms
Jean‐Philippe Krieger
Peptides (2020) Vol. 131, pp. 170342-170342
Open Access | Times Cited: 61
Jean‐Philippe Krieger
Peptides (2020) Vol. 131, pp. 170342-170342
Open Access | Times Cited: 61
Recent advances in understanding the role of glucagon-like peptide 1
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
F1000Research (2020) Vol. 9, pp. 239-239
Open Access | Times Cited: 51
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
F1000Research (2020) Vol. 9, pp. 239-239
Open Access | Times Cited: 51
The gut–brain axis: Identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders
Paul Richards, Nancy A. Thornberry, Shirly Pinto
Molecular Metabolism (2021) Vol. 46, pp. 101175-101175
Open Access | Times Cited: 49
Paul Richards, Nancy A. Thornberry, Shirly Pinto
Molecular Metabolism (2021) Vol. 46, pp. 101175-101175
Open Access | Times Cited: 49
The Role of Microglia in the Development of Neurodegenerative Diseases
Jae‐Won Lee, Wanjoo Chun, Hee Jae Lee, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 42
Jae‐Won Lee, Wanjoo Chun, Hee Jae Lee, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 42